Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity.
Cavaletti
G
G
Department of Neuroscience and Biomedical Technologies, University of Milan Bicocca, Monza, Italy. guido.cavaletti@unimib.it
Zanna
C
C
D004999:Amifostine / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005544:Forecasting; D005978:Glutathione / Q000627:therapeutic use; D006131:Growth Inhibitors / Q000627:therapeutic use; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines / Q000627:therapeutic use; D020932:Nerve Growth Factor / Q000187:drug effects / Q000627:therapeutic use; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced* / Q000188:drug therapy; D011837:Radiation-Protective Agents / Q000627:therapeutic use
D000970:Antineoplastic Agents; D006131:Growth Inhibitors; D015850:Interleukin-6; C507837:LIF protein, human; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines; D011837:Radiation-Protective Agents; D007334:Insulin-Like Growth Factor I; D020932:Nerve Growth Factor; D005978:Glutathione; D004999:Amifostine